. 2024 Oct 14;69:1607626. doi: 10.3389/ijph.2024.1607626

TABLE 2.

Sociodemographic and anamnestic determinants of vaccine literacy, negative perceptions and psychologic antecedents among senior Czechs responding to the Influenza Vaccination Survey, Czech Republic, April–August 2023 (n = 384).

Variable	Outcome	Functional Skills (Range: 4–16)	Sig.	Interactive/Critical Skills (Range: 7–28)	Sig.	Negative Perceptions (Range: 6–30)	Sig.	Confidence (Range: 3–15)	Sig.
Sex	Female	6 (4–8)	0.023	20 (15–24)	0.231	16 (12–19)	0.977	11 (9–12)	0.590
Sex	Male	7 (5–9)	0.023	19 (12–23)	0.231	16 (13–18)	0.977	10 (9–12)	0.590
Covered?	No	7 (5–9)	0.084	20 (13.25–23)	0.271	17 (12.25–19)	0.020	10 (8–11)	0.002
Covered?	Yes	6 (4–8)	0.084	21 (14.25–24)	0.271	15 (11.25–19)	0.020	11 (9–12)	0.002
Education	Elementary	9.5 (4.75–12)	0.020	21 (18.5–23.75)	0.652	11.5 (10.5–22.5)	0.871	11 (5.25–12.75)	0.978
	Secondary	7 (5–9)		20 (14–24)		16 (12–19)		11 (9–12)
	University	6 (4–8)		20 (13–24)		16 (11.75–19)		11 (9–12)
Employment	Pension Only	7 (5–9)	0.062	21 (14–24)	0.559	16 (12–19)	0.998	11 (9–12)	0.211
Employment	Pension + Additional Sources	6 (4–8)	0.062	20 (14–23)	0.559	16 (12–19)	0.998	10 (8.5–12)	0.211
Smoking	No	6 (4–8)	0.455	20 (14.5–24)	0.329	16 (12–19)	0.193	11 (9–12)	0.197
Smoking	Yes	7 (5–9)	0.455	19 (14–23)	0.329	17 (12–20)	0.193	10 (8–11)	0.197
BMI Level	Normal	7 (4–8)	0.929	20 (14–24)	0.567	16 (12–20)	0.817	10 (9–12)	0.670
	Overweight	6 (4–8)		21 (14–24)		15 (12–19)		11 (9–12)
	Obese	6 (5–9)		19 (12–24)		16 (12–18)		10 (9–12)
	Extremely Obese	6 (4.25–9)		20.5 (17.25–23.75)		16.5 (13.25–19)		10 (9–12)
Chronic Diseases	No	6 (4–8)	0.028	19 (13–23)	0.006	16 (12–20)	<0.001	10 (9–12)	0.035
Chronic Diseases	Yes	7 (5–9)	0.028	21 (17–24.5)	0.006	14 (11–18)	<0.001	11 (9–12)	0.035
Medications	No	5 (4–8)	0.015	19.5 (14–24)	0.694	17 (12.75–20)	0.018	10 (8–11.25)	0.112
Medications	Yes	7 (5–9)	0.015	20 (14–24)	0.694	16 (12–19)	0.018	11 (9–12)	0.112
COVID–19 Vaccine	No	7 (4,75–10)	0.574	20.5 (16.25–24)	0.597	20.5 (18–23)	<0.001	7 (4.75–9)	<0.001
COVID–19 Vaccine	Yes	6 (4–8)	0.574	20 (14–24)	0.597	15.5 (12–19)	<0.001	11 (9–12)	<0.001
COVID–19 Vaccine Doses	Primer Doses Only	7 (5–10)	0.124	19 (14–23)	0.636	19 (14–21)	<0.001	10 (8–11)	0.002
	Primer + 1 Booster	7 (4–9)		21 (14–25)		16 (12–18)		11 (9–12)
	Primer + 2 Boosters	6 (4–8)		20 (14–24)		14.5 (10.25–18)		11 (9–12)
Pneumococcal Vaccine	No	6 (4–8)	0.234	20 (14–23.75)	0.060	16 (12–20)	<0.001	10 (9–12)	<0.001
Pneumococcal Vaccine	Yes	7 (5–9)	0.234	21 (16–24.75)	0.060	13.5 (10–17)	<0.001	11 (10–12)	<0.001

Variable	Outcome	Complacency (Range: 1–5)	Sig.	Constraints (Range: 2–10)	Sig.	Calculation (Range: 3–15)	Sig.	Collective Responsibility (Range: 3–15)	Sig.
Sex	Female	2 (2–3)	0.891	4 (3–6)	0.513	12 (10–13)	0.016	10 (9–11)	0.403
Sex	Male	2 (2–3)	0.891	4 (3–6)	0.513	11 (9–12)	0.016	10 (8–12)	0.403
Covered?	No	3 (2–3)	0.045	5 (4–6)	0.085	12 (10–13)	0.142	9 (8–11)	0.008
Covered?	Yes	2 (2–3)	0.045	4 (3–6)	0.085	12 (9–12)	0.142	10 (9–12)	0.008
Education	Elementary	2 (1.75–2.75)	0.752	3.5 (2.75–4.75)	0.446	12 (10.5–15)	0.685	11 (6.75–12.5)	0.800
	Secondary	2 (2–3)		5 (3–6)		12 (10–12)		10 (9–11)
	University	2 (2–3)		4 (3–6)		12 (9–13)		10 (8–12)
Employment	Pension Only	2 (2–3)	0.836	4 (3–6)	0.330	12 (10–12)	0.492	10 (9–12)	0.022
Employment	Pension + Additional Sources	2 (2–3)	0.836	5 (3–6)	0.330	12 (9.5–13)	0.492	10 (8–11)	0.022
Smoking	No	2 (2–3)	0.985	4 (3–6)	0.449	12 (10–13)	0.207	10 (9–11)	0.598
Smoking	Yes	2 (2–3)	0.985	5 (4–6)	0.449	12 (10–12)	0.207	10 (8–12)	0.598
BMI Level	Normal	2 (2–3)	0.388	4 (3–6)	0.929	12 (9–12)	0.538	10 (8.5–12)	0.928
	Overweight	2 (2–3)		4 (3–6)		12 (10–13)		10 (9–11)
	Obese	3 (2–3)		4 (3–6)		11.5 (9–12)		10 (8–12)
	Extremely Obese	2 (2–3)		4.5 (3–6)		12 (10–13)		10 (9–11)
Chronic Diseases	No	3 (2–3)	0.002	5 (4–6)	0.006	12 (9–13)	0.609	10 (8–11)	<0.001
Chronic Diseases	Yes	2 (2–3)	0.002	4 (2.5–6)	0.006	12 (10–13)	0.609	11 (9–12)	<0.001
Medications	No	2 (2–3)	0.590	5 (3–7)	0.027	12 (10.75–13)	0.270	9.5 (7.75–11)	0.009
Medications	Yes	2 (2–3)	0.590	4 (3–6)	0.027	12 (9–13)	0.270	10 (9–12)	0.009
COVID–19 Vaccine	No	3 (2.75–3)	0.006	6.5 (5–8)	<0.001	12 (9.75–14.25)	0.307	7 (5–9)	<0.001
COVID–19 Vaccine	Yes	2 (2–3)	0.006	4 (3–6)	<0.001	12 (10–13)	0.307	10 (9–12)	<0.001
COVID–19 Vaccine Doses	Primer Doses Only	3 (2–3)	0.014	5 (4–7)	<0.001	12 (9–13)	0.196	9 (8–10)	<0.001
	Primer + 1 Booster	2 (2–3)		5 (4–6)		12 (9–12)		10 (8–11)
	Primer + 2 Boosters	2 (2–3)		4 (3–6)		12 (10–13)		10 (9–12)
Pneumococcal Vaccine	No	2 (2–3)	0.017	5 (4–6)	<0.001	12 (9.25–13)	0.913	10 (8–11)	<0.001
Pneumococcal Vaccine	Yes	2 (2–3)	0.017	4 (2–5)	<0.001	12 (10–13)	0.913	11 (10–12)	<0.001

Kruskal-Wallis test (H) and Mann–Whitney test (U) were used with a significance level < 0.05.

Bold font is for statistically significant values p < 0.05.